MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Income Overview

Net Income
-$96,760K
EPS
-$130
Unit: Thousand (K) dollars
Income Statement
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Net unrealized gains (losses) on marketable securities
-355
-770
-158
195
Total other comprehensive income (loss)
-355
-770
-158*
195
Research and development
70,811
75,365
72,992*
68,989
General and administrative
31,827
28,242
21,966*
14,366
Total operating expenses
102,638
103,607
94,957
83,355
Loss from operations
-102,638
-103,607
-94,957*
-83,355
Loss on debt extinguishment
-
-
-1,795*
-
Change in fair value of cvr liability
-
-
0*
-
Other income (expense), net
-11
-140
-6*
-3
Interest income
7,461
7,608
-87*
3,887
Interest expense
1,217
1,213
403*
1,459
Total other income, net
6,233
6,255
-2,291*
2,425
Net loss
-96,405
-97,352
-97,248*
-80,930
Comprehensive loss
-96,760
-98,122
-97,406
-80,735
Basic EPS
-130
-132.58
-1,440.925
-125.45
Diluted EPS
-130
-132.58
-1,440.925
-125.45
Basic Average Shares
39,414
67,414
67,600*
67,414
Diluted Average Shares
39,414
67,414
67,600*
67,414
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

Comprehensive loss-$96,760K (-31.32%↓ Y/Y)Interest income$7,461K (214.41%↑ Y/Y)Net loss-$96,405K (-31.11%↓ Y/Y)Total othercomprehensive income (loss)-$355K (-135.10%↓ Y/Y)Total other income,net$6,233K (203.60%↑ Y/Y)Interest expense$1,217K (287.58%↑ Y/Y)Other income(expense), net-$11K (-83.33%↓ Y/Y)Loss from operations-$102,638K (-35.80%↓ Y/Y)Net unrealizedgains (losses) on...-$355K (-135.10%↓ Y/Y)Total operatingexpenses$102,638K (35.80%↑ Y/Y)Research and development$70,811K (13.84%↑ Y/Y)General andadministrative$31,827K (137.89%↑ Y/Y)

Cogent Biosciences, Inc. (COGT)

Cogent Biosciences, Inc. (COGT)